In the current global home confinement situation due to the COVID‐19 outbreak, most
individuals are exposed to an unprecedented stressful situation of unknown duration. This …

Introduction: The purpose of this guideline is to establish clinical practice recommendations
for the pharmacologic treatment of chronic insomnia in adults, when such treatment is …

Background An outbreak of the 2019 novel coronavirus (COVID-19) has been ongoing in
China since January 2020. The threat of infection affects the work and life of most of the …

Importance Older adults with insomnia have a high risk of incident and recurrent depression.
Depression prevention is urgently needed, and such efforts have been neglected for older …

Insomnia is a major public health problem considering its high prevalence, impact on daily
life, co-morbidity with other disorders and societal costs. Cognitive behavioral treatment for …

Background: Because psychological approaches are likely to produce sustained benefits
without the risk for tolerance or adverse effects associated with pharmacologic approaches …

Insomnia disorder affects a large proportion of the population on a situational, recurrent or
chronic basis and is among the most common complaints in medical practice. The disorder …

Sleep disturbances including insomnia independently contribute to risk of inflammatory
disorders and major depressive disorder. This review and overview provides an integrated …

Chronic insomnia is defined by difficulties in falling asleep, maintaining sleep, and early
morning awakening, and is coupled with daytime consequences such as fatigue, attention …

Importance Sleep disturbances are most prevalent among older adults and often go
untreated. Treatment options for sleep disturbances remain limited, and there is a need for …